Educating Patients About Cancer Disparities Can Empower Them in Screening and Treatment Decisions

Video

When patients are aware of cancer disparities, it can empower them to be proactive about their care to close the prognostic gap between races.

When individuals are aware of breast cancer disparities, they can be proactive about screening and seeking quality care to ensure the best possible outcomes — and hopefully close the prognostic gaps that exist for certain groups, explained Dr. Beverly Moy.

Moy, who is the clinical director of the Breast Oncology Program at Massachusetts General Hospital in Boston, explained that Black women are 40% more likely to die of breast cancer compared to White women, and the difference in prognosis is even worse for younger women.

“We are making huge strides in advancing breast cancer outcomes and improving survival,” Moy said in an interview with CURE®. “We want to make sure that all of our patient populations benefit from those treatments.”

Transcript

It is extremely important for us to continually empower patients and their caregivers when it comes to cancer treatment screening and issues with cancer equity.

The fact is that if you are from certain underserved patient populations, you're far more likely to die of breast cancer compared to more advantaged populations. For example, if you're a black woman diagnosed with breast cancer, you're about 40% more likely to die of breast cancer compared to white women. And it's even worse, if you're a young black woman below age 50 diagnosed with breast cancer, you're twice as likely to die of breast cancer.

It’s extremely important for us as part of the oncology community to provide the information to patients and their caregivers to empower them to both make sure that they're screening for cancer — for breast cancer, in particular, because it's much more curable have found early — and if you're diagnosed with breast cancer, for patients and caregivers to seek out quality cancer care, because we are making huge strides in advancing breast cancer outcomes and improving survival. So we want to make sure that all of our patient populations benefit from those treatments.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Image of a woman with short blonde hair wearing a white blazer.
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey. If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key. “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained. READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Image of a woman with black hair.
Image of a woman with brown shoulder-length hair in front of a gray background that says CURE.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Related Content
Image of genetic testing.

Younger Survivors Have a Lower Risk of Secondary Primary Breast Cancer

May 1st 2024
Article

Genetic testing for women with breast cancer is important, as it may help determine the risk of developing secondary primary breast cancer.

Read More

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

February 12th 2024
Podcast

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews

Listen

Illustration of a woman with a brown pixie cut.

I Don’t Have All the Cancer Answers, But I Wish I Did

April 29th 2024
Article

After nearly 10 years as a breast cancer survivor, I've received so many questions I can't answer about cancer.

Read More

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

February 5th 2024
Podcast

One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.

Listen

Image of an X-ray showing the pancreas.

Meg Bennett Died, ‘Star Trek’ Actress Still Cancer-Free After 20 Years and More

April 26th 2024
Article

From “The Young and the Restless” actress dying of cancer to “Star Trek” actress 20 years pancreatic cancer-free, here’s what’s happening in the cancer space this week.

Read More

Image of FDA approval, what you need to know.

Enhertu Marks First Therapy Approved Across HER2-Positive Solid Tumors

April 24th 2024
Article

Treatment with Enhertu “is an unprecedented approval” for patients with HER2-positive solid tumors who did not have many options, an expert told CURE®.

Read More